← Back to Search

Behavioural Intervention

Attitudinal inoculation intervention for Depression

N/A
Waitlist Available
Led By Denis Nash, PhD
Research Sponsored by City University of New York, School of Public Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately post-intervention, 4 weeks post-intervention, and 6 months post-intervention
Awards & highlights

Study Summary

This trial aims to test the effectiveness of two different digital interventions compared to traditional public health messaging in increasing COVID-19 vaccine uptake among adults with and without anxiety or depression. One intervention focuses on using narrative

Who is the study for?
This trial is for undervaccinated adults in the US with anxiety or depression who are part of the CHASING COVID Cohort study, have had their last vaccine dose before September 11, 2023, and can read English. It aims to help those struggling with misinformation and vaccine hesitancy.Check my eligibility
What is being tested?
The effectiveness of two digital interventions—attitudinal inoculation and a CBT-informed approach—is being tested against standard public health messaging to increase COVID-19 vaccination rates among people with mental health symptoms.See study design
What are the potential side effects?
Since this trial focuses on digital interventions rather than medical treatments, traditional side effects like those seen with medications are not applicable. However, participants may experience emotional or psychological responses.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately post-intervention, 4 weeks post-intervention, and 6 months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately post-intervention, 4 weeks post-intervention, and 6 months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Self-reported receipt of COVID vaccine dose by 4 weeks post-intervention
Secondary outcome measures
Self-reported receipt of a COVID vaccine dose by 6 months post-intervention
Vaccine hesitancy post-intervention

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive behavioral therapy-informed interventionExperimental Treatment1 Intervention
Participants randomized to this arm will view a brief video using a CBT-informed approach and focused on addressing barriers to vaccination, with no inoculation messaging.
Group II: Attitudinal inoculation interventionExperimental Treatment1 Intervention
Participants randomized to this arm will view a brief video addressing one anti-vaccine "meta-narrative" or issue (e.g., concerns about the vaccine not working) most salient to the entire CHASING COVID study population (per recent historical data) and focused on bolstering resistance to mis/disinformation.
Group III: Conventional public health messagingActive Control1 Intervention
Participants randomized to this arm will view a brief video conveying conventional public health messaging adapted from a review of public health public service announcements, with no inoculation or CBT-informed messaging.

Find a Location

Who is running the clinical trial?

City University of New York, School of Public HealthLead Sponsor
25 Previous Clinical Trials
36,636 Total Patients Enrolled
2 Trials studying Depression
1,618 Patients Enrolled for Depression
University of North Carolina, Chapel HillOTHER
1,508 Previous Clinical Trials
4,189,482 Total Patients Enrolled
54 Trials studying Depression
32,198 Patients Enrolled for Depression
Denis Nash, PhDPrincipal InvestigatorCUNY Institute for Implementation Science in Population Health
4 Previous Clinical Trials
2,809 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently opportunities for individuals to enroll in this research study?

"As per the details provided on clinicaltrials.gov, this particular research endeavor is no longer open for participant recruitment. Its initial posting was on April 1st, 2024, with the last update made on April 3rd, 2024. However, amidst a pool of ongoing trials seeking volunteers at present, there are precisely 2339 active studies awaiting participants."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Brief Digital Intervention to Increase COVID-19 Vaccination Among Individuals With Anxiety or Depression
Denis Nash 2024. "Brief Digital Intervention to Increase COVID-19 Vaccination Among Individuals With Anxiety or Depression". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06119854.
All > Covid 19
~NaN spots leftby May 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top